© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes
aDepartment of Preclinical and Clinical Pharmacology, University of Firenze, Viale G. Pieraccini 6, 50139 Firenze, Italy
bInstitute of Internal Medicine and Cardiology, University of Firenze, Firenze, Italy
cInstitute of Pharmacology and Toxicology, Universitad Complutense de Madrid, Madrid, Spain
* Corresponding author. Tel.: +39-55-427-1264; fax: +39-55-427-1285 mugelli{at}pharm.unifi.it
Objective: Cardiac hypertrophy due to pressure overload is associated with several cellular electrophysiological alterations such as prolongation of action potential duration (APD), decrease in transient outward current (Ito) and occurrence of the pacemaker current If. These alterations may play a role in sudden arrhythmic death, which is a major risk factor in myocardial hypertrophy and failure. Since angiotensin II is a key signal for myocyte hypertrophy, we tested if an 8-week treatment of old spontaneously hypertensive rats (SHR) with the antagonist of type-1 angiotensin II receptor (AT1), losartan (10 mg/kg/day), was able to influence the cellular electrophysiologic remodeling associated with cardiac hypertrophy. Methods: Left ventricular myocytes were isolated from control (CTR) or losartan-treated (LOS) 18-month old SHR. Patch-clamped LVM were superfused with a normal Tyrode's solution (to measure action potential) or appropriately modified Tyrode's solution (to measure Ito and If). Results: Heart weight to body weight ratio (HW/BW) was significantly smaller in LOS (5.69±0.25 mg/g) than in CTR rats (6.67±0.37 mg/g; P<0.05). Membrane capacitance, an index of cell size, was significantly reduced in LOS (342±12, n=92) vs. CTR (422±14 pF, n=96, P<0.001). APD was significantly shorter in LOS than in CTR (at –60 mV: 197±23 vs. 277±19 ms, n=28, P<0.001); this effect was paralleled by a larger maximum Ito density in the LOS group (LOS: 15.1±1.4 pA/pF, CTR: 10.0±0.8 pA/pF) (n=27, P<0.02). If, elicited by hyperpolarizing steps (range: –60 to –130 mV), was consistently recorded in SHR cells; however, its maximal specific conductance was significantly lower in LOS than in CTR rats (28.6±3.6 vs. 54.2±8.0 pS/pF, n=55, P<0.001). Voltage of half-maximal activation (V1/2) of both Ito and If was unchanged by the treatment. Conclusions: AT1 receptor blockade with losartan prevents the development of myocyte hypertrophy and associated electrophysiological alterations in old SHR.
KEYWORDS APD, action potential duration; AT1, type-1 angiotensin II receptor; Cm, membrane capacitance; HW/BW, heart weight to body weight ratio; If, pacemaker current; Ito; transient outward current; RAS, renin–angiotensin system; SHR, spontaneously hypertensive rats; V1/2, voltage of half maximal activation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Biel, C. Wahl-Schott, S. Michalakis, and X. Zong Hyperpolarization-Activated Cation Channels: From Genes to Function Physiol Rev, July 1, 2009; 89(3): 847 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Plante, D. Lachance, J. Beaudoin, S. Champetier, E. Roussel, M. Arsenault, and J. Couet Comparative Study of Vasodilators in an Animal Model of Chronic Volume Overload Caused by Severe Aortic Regurgitation Circ Heart Fail, January 1, 2009; 2(1): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Charpentier Understanding the cardiac role of K2P channels: A new TASK for electrophysiologists Cardiovasc Res, July 1, 2007; 75(1): 5 - 6. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Saygili, O. R. Rana, E. Saygili, H. Reuter, K. Frank, R. H. G. Schwinger, J. Muller-Ehmsen, and C. Zobel Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2898 - H2905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Doronin, I. A. Potapova, Z. Lu, and I. S. Cohen Angiotensin Receptor Type 1 Forms a Complex with the Transient Outward Potassium Channel Kv4.3 and Regulates Its Gating Properties and Intracellular Localization J. Biol. Chem., November 12, 2004; 279(46): 48231 - 48237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Raimondi, P. De Paoli, E. Mannucci, G. Lonardo, L. Sartiani, G. Banchelli, R. Pirisino, A. Mugelli, and E. Cerbai Restoration of Cardiomyocyte Functional Properties by Angiotensin II Receptor Blockade in Diabetic Rats Diabetes, July 1, 2004; 53(7): 1927 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cerbai and A. Mugelli Angiotensin AT2 receptor: the younger sibling attracts attention Cardiovasc Res, April 1, 2004; 62(1): 7 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ferron, V. Capuano, Y. Ruchon, E. Deroubaix, A. Coulombe, and J.-F. Renaud Angiotensin II Signaling Pathways Mediate Expression of Cardiac T-Type Calcium Channels Circ. Res., December 12, 2003; 93(12): 1241 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Loennechen, U. Wisloff, G. Falck, and O. Ellingsen Effects of Cariporide and Losartan on Hypertrophy, Calcium Transients, Contractility, and Gene Expression in Congestive Heart Failure Circulation, March 19, 2002; 105(11): 1380 - 1386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R Sipido, P. G.A Volders, M. A Vos, and F. Verdonck Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res, March 1, 2002; 53(4): 782 - 805. [Abstract] [Full Text] [PDF]
|
|